GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » Research & Development

Perspective Therapeutics (FRA:AAJ) Research & Development : €23.01 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Perspective Therapeutics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Perspective Therapeutics's Research & Development for the three months ended in Mar. 2024 was €6.86 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €23.01 Mil.

Perspective Therapeutics Research & Development Historical Data

The historical data trend for Perspective Therapeutics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Research & Development Chart

Perspective Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 1.00 1.18 2.44 19.54

Perspective Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.09 5.22 5.36 5.58 6.86

Perspective Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €23.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics  (FRA:AAJ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Perspective Therapeutics Research & Development Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Perspective Therapeutics (FRA:AAJ) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (FRA:AAJ) » Definitions » Research & Development
Comparable Companies
AORT SSII AVNS CTKB FNA KIDS SILK VREX TMCI SIBN ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM ZBH ALGN
Traded in Other Exchanges
CATX:USA AAJ:Germany
Address
350 Hills Street, Suite 106, Richland, WA, USA, 99354
Website
https://www.perspectivetherapeutics.com
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company operates two reportable business segments: Brachytherapy and Drug Operations. It is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes.

Perspective Therapeutics (FRA:AAJ) Headlines

No Headlines